DK1526856T3 - Farmaceutisk sammensætning omfattende estetrolderivater til anvendelse i cancerterapi - Google Patents
Farmaceutisk sammensætning omfattende estetrolderivater til anvendelse i cancerterapiInfo
- Publication number
- DK1526856T3 DK1526856T3 DK03764245T DK03764245T DK1526856T3 DK 1526856 T3 DK1526856 T3 DK 1526856T3 DK 03764245 T DK03764245 T DK 03764245T DK 03764245 T DK03764245 T DK 03764245T DK 1526856 T3 DK1526856 T3 DK 1526856T3
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceutical composition
- cancer therapy
- estetrol
- derivatives
- estetrol derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02077812 | 2002-07-12 | ||
EP03075435 | 2003-02-14 | ||
PCT/NL2003/000513 WO2004006936A1 (fr) | 2002-07-12 | 2003-07-11 | Composition pharmaceutique comprenant des derives d'estetrol utilises dans la therapie anticancereuse |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1526856T3 true DK1526856T3 (da) | 2008-03-10 |
Family
ID=30116907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03764245T DK1526856T3 (da) | 2002-07-12 | 2003-07-11 | Farmaceutisk sammensætning omfattende estetrolderivater til anvendelse i cancerterapi |
Country Status (13)
Country | Link |
---|---|
US (2) | US9034854B2 (fr) |
EP (1) | EP1526856B1 (fr) |
CN (1) | CN100374116C (fr) |
AT (1) | ATE382356T1 (fr) |
AU (1) | AU2003253506A1 (fr) |
CA (1) | CA2492287C (fr) |
CY (1) | CY1107906T1 (fr) |
DE (1) | DE60318447T2 (fr) |
DK (1) | DK1526856T3 (fr) |
ES (1) | ES2299730T3 (fr) |
PT (1) | PT1526856E (fr) |
SI (1) | SI1526856T1 (fr) |
WO (1) | WO2004006936A1 (fr) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004006936A1 (fr) * | 2002-07-12 | 2004-01-22 | Pantarhei Biosciences B.V. | Composition pharmaceutique comprenant des derives d'estetrol utilises dans la therapie anticancereuse |
DE102007032468A1 (de) * | 2007-07-10 | 2009-01-15 | Brätter, Christian, Dr. | Transdermale Therapeutische Systeme, welche den Wirkstoff Anastrozol enthalten |
MX341561B (es) | 2011-06-01 | 2016-08-25 | Estetra Sprl | Proceso para la produccion de intermediarios de estetrol. |
MX342537B (es) | 2011-06-01 | 2016-10-04 | Estetra Sprl | Proceso para la produccion de intermediarios de estetrol. |
EP2383279A1 (fr) | 2011-07-19 | 2011-11-02 | Pantarhei Bioscience B.V. | Procédé de préparation d'estetrol |
WO2013034780A2 (fr) | 2012-12-20 | 2013-03-14 | Crystal Pharma, S.A.U. | Procédé de préparation de l'estétrol et de composés analogues |
CA2924255C (fr) | 2013-09-18 | 2022-11-22 | Crystal Pharma, S.A.U. | Procede pour la preparation d'estetrol |
GEP20217243B (en) | 2015-06-18 | 2021-04-26 | Sprl Estetra | Orodispersible dosage unit containing an estetrol component |
HUE054551T2 (hu) * | 2015-06-18 | 2021-09-28 | Estetra Sprl | Ösztetrolt tartalmazó, szájban diszpergálódó tabletta |
NO3106148T3 (fr) | 2015-06-18 | 2018-08-11 | ||
WO2016203009A1 (fr) * | 2015-06-18 | 2016-12-22 | Mithra Pharmaceuticals S.A. | Comprimé orodispersible contenant de l'estétrol |
KR20220144885A (ko) | 2016-08-05 | 2022-10-27 | 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 | 월경통 및 생리통의 관리방법 |
TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
JOP20200260A1 (ar) | 2018-04-19 | 2019-10-19 | Estetra Sprl | مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث |
ES2919626T3 (es) * | 2018-05-02 | 2022-07-27 | Estetra Sprl | Régimen de tratamiento para el tratamiento de cáncer de mama avanzado positivo para el receptor de estrógenos |
HU231240B1 (hu) | 2019-09-03 | 2022-04-28 | Richter Gedeon Nyrt. | Ipari eljárás nagytisztaságú ösztetrol hatóanyag előállítására |
Family Cites Families (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3440320A (en) * | 1964-06-18 | 1969-04-22 | Mortimer D Sackler | Chelated suppository and method of using same |
US3797494A (en) * | 1969-04-01 | 1974-03-19 | Alza Corp | Bandage for the administration of drug by controlled metering through microporous materials |
DE2336433A1 (de) | 1973-07-13 | 1975-04-03 | Schering Ag | 1.3-oxygenierte 8 alpha-oestratriene |
DE2426779A1 (de) | 1974-05-31 | 1975-12-18 | Schering Ag | 1.3-oxygenierte 8 alpha-oestratriene |
DE2336434A1 (de) | 1973-07-13 | 1975-04-17 | Schering Ag | 1.3-oxygenierte 8 alpha-oestratriene |
US4722941A (en) * | 1978-06-07 | 1988-02-02 | Kali-Chemie Pharma Gmbh | Readily absorbable pharmaceutical compositions of per se poorly absorbable pharmacologically active agents and preparation thereof |
US4460372A (en) * | 1981-02-17 | 1984-07-17 | Alza Corporation | Percutaneous absorption enhancer dispenser for use in coadministering drug and percutaneous absorption enhancer |
US4573996A (en) * | 1984-01-03 | 1986-03-04 | Jonergin, Inc. | Device for the administration of an active agent to the skin or mucosa |
US4624665A (en) * | 1984-10-01 | 1986-11-25 | Biotek, Inc. | Method of transdermal drug delivery |
US4937238A (en) * | 1986-03-04 | 1990-06-26 | The Board Of Regents Of The University Of Nebraska | Prevention of mammary carcinoma |
US4762717A (en) * | 1986-03-21 | 1988-08-09 | The General Hospital Corporation | Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive |
US5223261A (en) * | 1988-02-26 | 1993-06-29 | Riker Laboratories, Inc. | Transdermal estradiol delivery system |
US5043331A (en) | 1989-06-15 | 1991-08-27 | Orion-Yhtyma Oy | Treatment of postmenopausal disorders |
US5130137A (en) * | 1989-08-09 | 1992-07-14 | The General Hospital Corporation | Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use in treating benign ovarian secretory disorders |
JPH04235171A (ja) | 1990-07-26 | 1992-08-24 | Sumitomo Chem Co Ltd | スルホヒドロキサム酸誘導体、その製造法およびそれを有効成分とする除草剤 |
US5063507A (en) * | 1990-09-14 | 1991-11-05 | Plains Cotton Cooperative Association | Goods database employing electronic title or documentary-type title |
US5211952A (en) * | 1991-04-12 | 1993-05-18 | University Of Southern California | Contraceptive methods and formulations for use therein |
US5340586A (en) * | 1991-04-12 | 1994-08-23 | University Of Southern California | Methods and formulations for use in treating oophorectomized women |
US5340585A (en) | 1991-04-12 | 1994-08-23 | University Of Southern California | Method and formulations for use in treating benign gynecological disorders |
US5468736A (en) * | 1993-02-25 | 1995-11-21 | The Medical College Of Hampton Road | Hormone replacement therapy |
US5895783A (en) | 1993-07-16 | 1999-04-20 | Schering Aktiengesellschaft | Treatment of preeclampsia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor |
NL9301562A (nl) * | 1993-09-09 | 1995-04-03 | Saturnus Ag | Preparaat voor substitutietherapie. |
DE4344405C2 (de) * | 1993-12-24 | 1995-12-07 | Marika Dr Med Ehrlich | Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption |
WO1996003929A1 (fr) | 1994-08-04 | 1996-02-15 | Biex, Inc. | Procede de prediction d'un accouchement premature a l'aide d'estetrol (e4) comme indicatuer |
DE4429374C1 (de) * | 1994-08-12 | 1996-02-01 | Jenapharm Gmbh | Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente |
ES2247710T3 (es) | 1997-06-20 | 2006-03-01 | Akzo Nobel N.V. | Antagonista de gonadotropina. |
DE19739916C2 (de) * | 1997-09-11 | 2001-09-13 | Hesch Rolf Dieter | Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen |
US6214815B1 (en) * | 1998-12-23 | 2001-04-10 | Ortho-Mcneil Pharmaceuticals, Inc. | Triphasic oral contraceptive |
DE19917930A1 (de) | 1999-04-15 | 2000-10-19 | Schering Ag | Ent-Steroide als selektiv wirksame Estrogene |
JP2003527310A (ja) | 1999-04-16 | 2003-09-16 | イエナフアルム ゲーエムベーハー ウント ツェーオー. カーゲー | エストロゲンを局部的に皮内投与するための医薬品組成物または化粧品組成物 |
US7273932B1 (en) | 1999-05-28 | 2007-09-25 | The University Of Cincinnati | Antisense oligonucleotides for fertility and menstrual cycle regulation and for chemopreventive and chemotherapeutic use |
WO2001030356A1 (fr) | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation |
US20020012710A1 (en) * | 1999-11-29 | 2002-01-31 | Rimonest Ltd. | Pomegranate products useful in improving health and methods of use thereof |
EP1286664B1 (fr) | 2000-05-12 | 2007-07-25 | Oregon Health and Science University | Combinaison de faibles doses d'oestrogene et d'agents immunotherapeutiques pour traiter les maladies immunitaires |
WO2002030355A2 (fr) * | 2000-10-11 | 2002-04-18 | Laura Kragie | Composition et procede destines a reduire les effets indesirables et/ou ameliorer l'efficacite d'agents inhibant l'aromatase |
AU2002240949A1 (en) * | 2001-03-21 | 2002-10-03 | Schering Aktiengesellschaft | Pharmaceutical combined preparations containing aromatase inhibitors and substances having an estrogen effect in addition to the use thereof for producing a medicament for estrogen-replacement-therapy |
US6936599B2 (en) * | 2001-04-25 | 2005-08-30 | The Regents Of The University Of California | Estriol therapy for multiple sclerosis and other autoimmune diseases |
WO2002094276A1 (fr) | 2001-05-18 | 2002-11-28 | Pantarhei Bioscience B.V. | Composition pharmaceutique a utiliser en therapie de remplacement d'hormones |
EP1260225A1 (fr) | 2001-05-18 | 2002-11-27 | Pantarhei Bioscience B.V. | Compositions pharmaceutiques pour le traitement hormonal substitutif |
WO2002100877A1 (fr) | 2001-06-11 | 2002-12-19 | Southwest Foundation For Biomedical Research | Nouveaux analogues 2-alcoxyestradiol a activite antiproliferative et antimitotique |
WO2004006936A1 (fr) * | 2002-07-12 | 2004-01-22 | Pantarhei Biosciences B.V. | Composition pharmaceutique comprenant des derives d'estetrol utilises dans la therapie anticancereuse |
CA2503549C (fr) * | 2002-10-23 | 2012-07-10 | Pantarhei Bioscience B.V. | Compositions pharmaceutiques comprenant des derives d'estetrol a utiliser dans le traitement du cancer |
ATE340580T1 (de) * | 2003-05-22 | 2006-10-15 | Pantarhei Bioscience Bv | Verwendung von zusammensetzungen enthaltend ein oestrogen zur behandlung und verhinderung von muskelskelettschmerzen |
-
2003
- 2003-07-11 WO PCT/NL2003/000513 patent/WO2004006936A1/fr active IP Right Grant
- 2003-07-11 CA CA2492287A patent/CA2492287C/fr not_active Expired - Lifetime
- 2003-07-11 PT PT03764245T patent/PT1526856E/pt unknown
- 2003-07-11 EP EP03764245A patent/EP1526856B1/fr not_active Expired - Lifetime
- 2003-07-11 US US10/521,040 patent/US9034854B2/en active Active
- 2003-07-11 AT AT03764245T patent/ATE382356T1/de not_active IP Right Cessation
- 2003-07-11 ES ES03764245T patent/ES2299730T3/es not_active Expired - Lifetime
- 2003-07-11 CN CNB038217449A patent/CN100374116C/zh not_active Expired - Lifetime
- 2003-07-11 AU AU2003253506A patent/AU2003253506A1/en not_active Abandoned
- 2003-07-11 SI SI200331093T patent/SI1526856T1/sl unknown
- 2003-07-11 DE DE60318447T patent/DE60318447T2/de not_active Expired - Lifetime
- 2003-07-11 DK DK03764245T patent/DK1526856T3/da active
-
2008
- 2008-03-13 CY CY20081100284T patent/CY1107906T1/el unknown
-
2015
- 2015-01-20 US US14/600,795 patent/US10201611B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CA2492287A1 (fr) | 2004-01-22 |
AU2003253506A1 (en) | 2004-02-02 |
US20150133413A1 (en) | 2015-05-14 |
ATE382356T1 (de) | 2008-01-15 |
US10201611B2 (en) | 2019-02-12 |
DE60318447D1 (de) | 2008-02-14 |
SI1526856T1 (sl) | 2008-04-30 |
PT1526856E (pt) | 2008-04-11 |
US20060063723A1 (en) | 2006-03-23 |
US9034854B2 (en) | 2015-05-19 |
EP1526856A1 (fr) | 2005-05-04 |
EP1526856B1 (fr) | 2008-01-02 |
DE60318447T2 (de) | 2009-01-02 |
WO2004006936A1 (fr) | 2004-01-22 |
CN100374116C (zh) | 2008-03-12 |
CN1681513A (zh) | 2005-10-12 |
ES2299730T3 (es) | 2008-06-01 |
CY1107906T1 (el) | 2013-09-04 |
WO2004006936A8 (fr) | 2005-03-03 |
CA2492287C (fr) | 2011-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1107906T1 (el) | Φαρμακευτικη συνθεση που περιλαμβανει παραγωγα οιστετρολης για χρηση στην θεραπεια κατα του καρκινου | |
NO20062504L (no) | Sammensetninger og doseringsformer for forbedret absorpsjon | |
BRPI0516531A (pt) | imunoterapia de distúrbios auto-imunes | |
DK1556058T3 (da) | Farmaceutiske præparater omfattende östetrolderivater til anvendelse i cancerterapi | |
WO2005084296A3 (fr) | Composes tricycliques fusionnes en tant qu'inhibiteurs de 17beta-hydroxysteroide deshydrogenase 3 | |
TW200616650A (en) | Semi-solid delivery vehicle and pharmaceutical compositions | |
WO2007149406A3 (fr) | Polypeptides facteurs ix de la coagulation modifiés et leur utilisation thérapeutique | |
IL153297A0 (en) | Compounds and compositions for delivering active agents | |
MX2009010289A (es) | Composiciones para administracion nasal. | |
BR0107535A (pt) | Uso de carotenóides e forma de dosagem unitária destes | |
MY143407A (en) | Indazole derivatives as inhibitors of hormone sensitive lipase | |
TW200603787A (en) | Topical preparations containing ambroxol | |
NO20091191L (no) | Fremgangsmater for behandling av kreft, innbefattende administrering av et vitamin D preparat og et ytterligere terapeutisk middel, og sammensetninger som inneholder de samme | |
ATE275393T1 (de) | Feste dispersionen mit nitrataktiven wirkstoffen | |
MXPA03007857A (es) | Compuestos y composiciones para entregar agentes activos. | |
BRPI0416275A (pt) | métodos de tratar, controlar ou prevenir um cáncer especìfico e uma doença associada com angiogênese indesejada | |
CL2008002082A1 (es) | Compuestos derivados de 6-fenil-1h-imidazo[4,5-c]piridina-4-carbonitrilo, inhibidores de catepsina s y catepsina k; composicion farmaceutica; y uso en el tratamiento de osteoporosis, aterosclerosis, inflamacion, entre otras enfermedades. | |
SE0400346D0 (sv) | Steroids for cancer treatment | |
EP1503748A4 (fr) | Medicaments servant a attenuer la neurotoxicite induite par le taxane | |
TN2009000119A1 (en) | Combination drug | |
AR030140A1 (es) | Composiciones derivadas de la 2-piridinamina y metodos relacionados | |
EA200500671A1 (ru) | Фармацевтический состав оланзапина | |
BRPI0418801A (pt) | métodos de tratamento, controle ou prevenção de um cáncer especìfico, e de uma doença associada com angiogênese indesejada, de redução ou prevenção de um efeito adverso, composição farmacêutica, e, kit | |
JO2492B1 (en) | A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients | |
ZA200605900B (en) | Glycosylated steroid derivatives with anti-migratory activity |